Find new businesses and brands
Trademark Search > Trademark Category > Computer & Software Services & Scient... > ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL
ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL
By: Bristol-Myers Squibb Company tweet it Tweet Logo Share on Facebook
Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Perfect for these industries

Words that describe this logo

medical   scientific   research       conducting   clinical   trials   relating   pharmaceutical   preparations   human   use  
This is a brand page for the ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL trademark by Bristol-Myers Squibb Company in New York, NY, 10154. Write a review about a product or service associated with this ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL trademark. Or, contact the owner Bristol-Myers Squibb Company of the ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL trademark.
On Wednesday, July 27, 2011, a U.S. federal trademark registration was filed for ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL by Bristol-Myers Squibb Company, New York, NY 10154. The USPTO has given the ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL trademark serial number of 85382237. The current federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED. The correspondent listed for ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL is MARILYN F. KELLY of BRISTOL-MYERS SQUIBB COMPANY, TRADEMARKS DEPT. - MAILSTOP D33-05, P.O. BOX 4000 PRINCETON NJ 08648-4000 . The ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL trademark is filed in the category of Computer & Software Services & Scientific Services . The description provided to the USPTO for ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL is Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use.
Word Mark: ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL
Status/
Status Date:
ABANDONED - NO STATEMENT OF USE FILED
9/9/2013

Serial Number: 85382237
Filing Date: 7/27/2011
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 6/12/2012
Last Applicant/Owner: Bristol-Myers Squibb Company
New York, NY 10154
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: ("ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL")
Correspondent:
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT. - MAILSTOP D33-05
P.O. BOX 4000
PRINCETON NJ 08648-4000
Classification Information
International Class Code(s): 042
US Class Code(s): 100, 101
Primary Class: Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
Class(es) Status: Active
First Use Anywhere: NOT PROVIDED
First Use In Commerce: NOT PROVIDED
 

LegalForce is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce network! You can register your trademark in 100+ countries in the world through LegalForce Network.

LegalForce Network can help you incorporate a business around your ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL trademark in less than 5 minutes. LegalForce makes the process easy and convenient, so start now!

LegalForce.com is a free search engine of publicly available government records. LegalForce.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>
trademark
100% Satisfaction Guarantee
protect your valuable brand now.
 
How it works?
  1. Tell us about your business or product. Describe how your business or product is being used.
  2. Register your mark in 100+ countries. Just $159 + government fees!
What our customers say:
I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.
-Camryn, Surrey, UK
Keep Track of this Brand.
Trademark Watch Services
Keep track of how your trademark is being used. Available in the United States and in more than 100 countries. Round-the-clock monitoring. Monthly report on potential infringement.
Trademark Watch Services read more...
Current Trademark Status:
9/9/2013
ABANDONED - NO STATEMENT OF USE FILED
Free Trademark Search:
Search:
Correspondent Search:
MARILYN F. KELLY is a correspondent of ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL trademark.
Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
 
Available, Get it at $159

This mark may be available for re-registration. You can apply for it through LegalForce at a low cost of $159!

LegalForce.com will perform a final search in order to verify that this mark is available for re-registration. All LegalForce services are backed by a 100% satisfaction guarantee.

Commerce Images Usage

No Logos Found New Commerce Use.

Company Commercial Videos

Kevin Sharp Commercial for Bristol Myers Squibb
Published on:7/25/2009 8:38:53 AM
Bristol-Myers Squibb with Lance Armstrong (2000)
Published on:1/29/2013 7:10:38 PM
Beautiful people
Published on:4/25/2008 9:37:44 AM
Biopharmaceutical company, Bristol-Myers Squibb, to bring nearly 600 high-paying jobs to Tampa Bay
Published on:7/19/2013 9:52:08 AM
LegalForce lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!